EndoClot Adhesive ECA2302
by EndoClot Plus Co., Ltd. 7 variants
Ref ECA2302
Active
Valid until
No date given
FDA recalls
None found
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/MDD EUDAMED | NumberB-46972011720135 | Date27 Feb 2026 | StatusActive |
| United States | FDA 510(k) 510(k) | NumberK190677 | Date29 Jan 2021 | StatusActive |
Official records
- EUDAMED public site B-46972011720135
- FDA 510(k) database K190677
- FDA 510(k) database K191254
- FDA 510(k) database K162197
Across registries
- EUDAMED Basic UDI-DI B-46972011720135 registered 27 Feb 2026 Active
- FDA 510(k) K190677 decided 29 Jan 2021 Active
Timeline
- Cleared FDA 510(k) K162197
- Cleared FDA 510(k) K191254
- Cleared FDA 510(k) K190677
- Registered EUDAMED B-46972011720135
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- United States
- European Union
Specification
- Full name
- EndoClot®
- Model / reference
- ECA2302
- Primary DI / UDI-DI
- 46972011720135, 56972011720132, 36972011720138, 16972011720134, 26972011720131
- Basic UDI-DI
- B-46972011720135, B-56972011720132, B-36972011720138, B-16972011720134, B-26972011720131
- EMDN code
- M040504 Inorganic haemostatic devices
- Device class
- Class IIa
- EU registration type
- Legacy device (under a directive)
- EU market of registration
- Italy
Manufacturer details
- EUDAMED SRN
- CN-MF-000003672
- Authorised representative
- ClotPlus Limited IE-AR-000002109
Overview
AI-generated summary, 1 Oct 2026
The EndoClot Adhesive ECA2302 is a sterile, single-use hemostatic adhesive classified under nomenclature code M040504. Designed as a polysaccharide-based adhesive, it is intended for topical application to control bleeding in the gastrointestinal tract by forming a cohesive seal at the wound site. Its formulation is engineered to promote rapid clotting and tissue adhesion, reducing the risk of post-procedural hemorrhage during endoscopic interventions.
Supplied as a ready-to-use adhesive, the EndoClot ECA2302 is non-reusable and non-implantable, with no active components. It is packaged in a sterile, single-use format and requires no reprocessing. The device adheres to FDA 510(k) and MDD regulatory standards, ensuring compliance with medical device legislation. Storage conditions are not specified but must align with sterility requirements to maintain efficacy until use.
From the manufacturer
In 2014, EndoClot Plus Co., Ltd. was established in Suzhou Industrial Park, China to manufacture the EndoClot ® product lines including EndoClot ® PHS, EndoClot ® Adhesive and EndoClot ® Submucosal Injection System.
EndoClot ® Polysaccharide Hemostatic System (EndoClot ® PHS) EndoClot ® PHS is a single use medical device consisting of Absorbable Modified Polymers (AMP ®) and a unique powder delivery system (applicator). It is a safe and effective method to control bleeding in both upper and lower GI tracts.
Similar devices in this category
Other devices filed under INORGANIC HAEMOSTATIC DEVICES.
- QUIKCLOT IPN928798 636 by TELEFLEX INCORPORATED
- StatSeal DL016 by Biolife, LLC
- StatSeal LP007 by Biolife, LLC
- ViscoStat Clear S646 by ULTRADENT PRODUCTS, INC.
- QUIKCLOT IPN928794 350 by TELEFLEX INCORPORATED
- TOURNIQUET CE/MDR-TM-01 by Shenzhen TMI Medical Supplies Co., ltd
- Astringedent X 112 by ULTRADENT PRODUCTS, INC.
- StatSeal® DM015 by BIOLIFE, L.L.C.
- QuikClot 467Z by Z-Medica, LLC